These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical pharmacotherapy for obesity: current drugs and those in advanced development. Halford JC Curr Drug Targets; 2004 Oct; 5(7):637-46. PubMed ID: 15473253 [TBL] [Abstract][Full Text] [Related]
8. Drug strategies for the treatment of obesity. Alemany M; Remesar X; Fernández-López JA IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679 [TBL] [Abstract][Full Text] [Related]
9. Medicinal strategies in the treatment of obesity. Bray GA; Tartaglia LA Nature; 2000 Apr; 404(6778):672-7. PubMed ID: 10766254 [TBL] [Abstract][Full Text] [Related]
10. Long-term pharmacotherapy for obesity and overweight. Padwal R; Li SK; Lau DC Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004 [TBL] [Abstract][Full Text] [Related]
12. New and emerging drug molecules against obesity. George M; Rajaram M; Shanmugam E J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):65-76. PubMed ID: 24064009 [TBL] [Abstract][Full Text] [Related]
13. Drug treatment of obesity: established and emerging therapies. Isidro ML; Cordido F Mini Rev Med Chem; 2009 Jun; 9(6):664-73. PubMed ID: 19519492 [TBL] [Abstract][Full Text] [Related]
14. Treating obesity: pharmacology of energy expenditure. Clapham JC Curr Drug Targets; 2004 Apr; 5(3):309-23. PubMed ID: 15058315 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of obesity: targets and perspectives. Chiesi M; Huppertz C; Hofbauer KG Trends Pharmacol Sci; 2001 May; 22(5):247-54. PubMed ID: 11339976 [TBL] [Abstract][Full Text] [Related]
16. Possible anti-obesity therapeutics from nature--a review. Yun JW Phytochemistry; 2010 Oct; 71(14-15):1625-41. PubMed ID: 20732701 [TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical approaches to the treatment of obesity. Jandacek RJ; Woods SC Drug Discov Today; 2004 Oct; 9(20):874-80. PubMed ID: 15475320 [TBL] [Abstract][Full Text] [Related]
18. New molecular targets in the pathophysiology of obesity and available treatment options under investigation. Valsamakis G; Lois K; Kumar S; Mastorakos G Clin Obes; 2014 Aug; 4(4):209-19. PubMed ID: 25826792 [TBL] [Abstract][Full Text] [Related]
19. Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome. Maksimov ML; Svistunov AA; Tarasov VV; Chubarev VN; Ávila-Rodriguez M; Barreto GE; Dralova OV; Aliev G Curr Pharm Des; 2016; 22(7):895-903. PubMed ID: 26648466 [TBL] [Abstract][Full Text] [Related]
20. Weighing the options in the pharmacotherapy of obesity. Wieland HA; Hamilton BS Int J Clin Pharmacol Ther; 2001 Sep; 39(9):406-14. PubMed ID: 11563688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]